Correlation between array-comparative genomic hybridization-defined genomic gains and losses and survival: identification of 1p31-32 deletion as a prognostic factor in myeloma
Wee Joo Chng, Morie Abraham Gertz, T-H Chung et al. · Leukemia · 2010
Cited by 47 works. doi:10.1038/leu.2010.21
Authors
- Wee Joo Chng
- Morie Abraham Gertz
- Scott Van Wier
- Jonathan J. Keats
- Angela S. Baker
- Peter Leif Bergsagel
- John David Carpten
- Rafaël Fonseca
References
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma
- Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome
- Clinical and biologic implications of recurrent genomic aberrations in myeloma
- Genetics and Cytogenetics of Multiple Myeloma
- A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1
- Multiple myeloma
- Improved cytogenetics in multiple myeloma: a study of 151 patients including 117 patients at diagnosis
- High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients
- Hypodiploidy is a major prognostic factor in multiple myeloma
- In multiple myeloma, t(4;14)(p16;q32) is an adverse prognostic factor irrespective of FGFR3 expression